Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Goodwill: 2021-2023

  • InMed Pharmaceuticals' Goodwill was N/A to $1.1 million in Q2 2023 from the same period last year, while for Jun 2023 it was $1.1 million, marking a year-over-year change of. This contributed to the annual value of $1.1 million for FY2023, which is N/A change from last year.
  • InMed Pharmaceuticals' Goodwill amounted to $1.1 million in Q2 2023, which was down 46.74% from $2.0 million recorded in Q1 2022.
  • Over the past 5 years, InMed Pharmaceuticals' Goodwill peaked at $2.0 million during Q4 2021, and registered a low of $1.1 million during Q2 2023.
  • Over the past 3 years, InMed Pharmaceuticals' median Goodwill value was $2.0 million (recorded in 2022), while the average stood at $1.7 million.